- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Breast Cancer Survivors Prefer Oncologist Follow-Up
In breast cancer survivors participating in a survivorship study, follow-up visits with an oncologist as compared to other types of clinicians are perceived to minimize stress around the visit, decrease worrying about cancer, and improve the self-perceived impact of follow-up visits on cancer survival, according to research published online Dec. 12 in the Journal of Clinical Oncology.
Erica L. Mayer, M.D., M.P.H., of the Dana-Farber Cancer Institute in Boston, and colleagues analyzed data from 218 breast cancer survivors (median age, 57.5 years) who participated in a general survivorship study and completed an extra breast cancer-specific questionnaire.
The purpose of the study was to determine survivors' comfort with different clinician types and telephone/Internet-based virtual visits as components of survivorship care. Perceptions of the impact of follow-up visits on survival, level of worry about cancer, and stress related to the visit were evaluated for each clinician type and for virtual visits.
Read the full story at: http://www.physiciansbriefing.com/Article.asp?AID=659695
Sources: Health Day; Journal of Clinical Oncology
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
